OBJECTIVES: To determine the anticipated participation in a prophylactic AIDS vaccine trial and to identify perceived benefits and barriers to enrollment of HIV-seronegative volunteers at risk of HIV infection in northern Thailand. DESIGN: A cross-sectional survey. METHODS: Subjects interviewed in a cross-sectional survey included female commercial sex workers (n = 215), men attending sexually transmitted disease clinics (n = 219), conscripts in the Royal Thai Army (n = 1453), and men discharged from the army (n = 293) who had returned to civilian life. We determined AIDS vaccine knowledge and attitudes, perceived vulnerability to HIV infection, barriers and incentives to participate in a future vaccine trial and agreement to participate in a randomized trial. RESULTS: Awareness of vaccines (88-97%) and AIDS vaccine development efforts (62-77%) were common and viewed to be a complement to behavior change (74-94%). Approximately 25% of subjects would definitely join a trial if asked, and an additional 38% would accept an AIDS vaccine if they were convinced it would be safe and effective. Important barriers to participation included concerns with discrimination (16-45%), short- (37-60%) and long-term (30-55%) vaccine side-effects, fear of disability and death (36-58%), and beliefs that partners would refuse to have sex (24-49%) after immunization. The principal inducement to join a trial was health insurance (62%). CONCLUSION: Potential HIV vaccine trial participants have several fears of joining a vaccine study at this time. Information derived from Phase I/II trials is needed to address these concerns if enrollment in efficacy trials is to be successful in the near future.
OBJECTIVES: To determine the anticipated participation in a prophylactic AIDS vaccine trial and to identify perceived benefits and barriers to enrollment of HIV-seronegative volunteers at risk of HIV infection in northern Thailand. DESIGN: A cross-sectional survey. METHODS: Subjects interviewed in a cross-sectional survey included female commercial sex workers (n = 215), men attending sexually transmitted disease clinics (n = 219), conscripts in the Royal Thai Army (n = 1453), and men discharged from the army (n = 293) who had returned to civilian life. We determined AIDS vaccine knowledge and attitudes, perceived vulnerability to HIV infection, barriers and incentives to participate in a future vaccine trial and agreement to participate in a randomized trial. RESULTS: Awareness of vaccines (88-97%) and AIDS vaccine development efforts (62-77%) were common and viewed to be a complement to behavior change (74-94%). Approximately 25% of subjects would definitely join a trial if asked, and an additional 38% would accept an AIDS vaccine if they were convinced it would be safe and effective. Important barriers to participation included concerns with discrimination (16-45%), short- (37-60%) and long-term (30-55%) vaccine side-effects, fear of disability and death (36-58%), and beliefs that partners would refuse to have sex (24-49%) after immunization. The principal inducement to join a trial was health insurance (62%). CONCLUSION: Potential HIV vaccine trial participants have several fears of joining a vaccine study at this time. Information derived from Phase I/II trials is needed to address these concerns if enrollment in efficacy trials is to be successful in the near future.
Entities:
Keywords:
Acquired Immunodeficiency Syndrome; Asia; Attitude; Behavior; Cross Sectional Analysis; Delivery Of Health Care; Developing Countries; Diseases; Government; Health; Health Services; Hiv Infections; Immunization; Infections; Military Personnel; Obstacles; Organization And Administration; Political Factors; Primary Health Care; Psychological Factors; Reproductive Tract Infections; Research Methodology; Sexually Transmitted Diseases; Southeastern Asia; Thailand; Vaccination; Vaccines; Viral Diseases
Authors: R A Jenkins; K Torugsa; L E Markowitz; C J Mason; V Jamroentana; A E Brown; S Nitayaphan Journal: Sex Transm Infect Date: 2000-10 Impact factor: 3.519
Authors: Gambo Aliyu; Mukhtar Mohammad; Ahmed Saidu; Prosanta Mondal; Man Charurat; Alash'le Abimiku; Abdulsalami Nasidi; William Blattner Journal: AIDS Care Date: 2010-10
Authors: Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon Journal: AIDS Behav Date: 2013-02
Authors: Emmanuel Kiawi; Eleanor McLellan-Lemal; Jembia Mosoko; Kata Chillag; Pratima L Raghunathan Journal: BMC Int Health Hum Rights Date: 2012-06-22
Authors: M Florencia Etcheverry; Jennifer L Evans; Emilia Sanchez; Eva Mendez-Arancibia; Mercé Meroño; José M Gatell; Kimberly Page; Joan Joseph Journal: Hum Vaccin Immunother Date: 2013-01-04 Impact factor: 3.452